Young Australian women who got Merck & Co.'s HPV vaccine Gardasil were five to 20 times more likely to have severe allergic reactions than women in comparable vaccine programs. The study included 114,000 women, and 12 had anaphylactic reactions. Researchers suggest the higher reaction rates may be due to better surveillance programs to identify the reactions.

Full Story:

Related Summaries